MDACC Study No:2012-0823 ( NCT No: NCT01737671)
Title:Methotrexate Infusion into the Fourth Ventricle in Children with Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Principal Investigator:Soumen Khatua
Treatment Agent:Leucovorin; Methotrexate
Study Status:Closed
Study Description:The goal of this clinical research study is to learn if it is safe to receive
methotrexate through the fourth ventricle of the brain in patients with brain

Methotrexate is designed to block cancer cells from dividing, which may slow or
stop their growth and spread throughout the body. This may cause the cancer
cells to die.
Hide details for General InformationGeneral Information

Disease Group:Pediatrics
Phase of Study:N/A
Treatment Agents:Leucovorin
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:N/A
Return Visit:
Home Care:

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Soumen Khatua
Dept: Pediatrics
For Clinical Trial Enrollment:713-792-5235
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults